COVID-19 Vaccine Boosters in Patients With CKD

NCT05022329 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
273
Enrollment
OTHER
Sponsor class

Stopped Trial participants became eligible to receive their 4th dose of the COVID-19 vaccine vaccine thus data collected from the 12 month follow-up after 3rd dose vaccine, as per current protocol, would not not be relevant to the study outcomes.

Conditions

Interventions

Sponsor

Sunnybrook Health Sciences Centre

Collaborators